You might also read
Articles linked to this work by shared authors, journal, and citation graph.
Anthony L Asher1, Nikita Lakomkin2, Praveen V Mummaneni3
1Neuroscience Institute, Atrium Health and Carolina Neurosurgery & Spine Associates, Charlotte , North Carolina , USA.
This study defines optimal minimum clinically important differences (MCIDs) for patient-reported outcome metrics (PROMs) in cervical spondylotic myelopathy (CSM). A 30% improvement is ideal for NDI and pain scales, while EQ-5D and mJOA scores require specific numeric or severity-adjusted MCIDs.
Area of Science:
Background:
Purpose of the Study:
Main Methods:
Main Results:
Conclusions: